Showing results (881-890 of 2,815) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|September 24, 2009
Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trialAngel L Comulada, Eric Renard, Masako Nakano, et al.Diabetes Technology & Therapeutics|August 25, 2009
Reduction of glycosylated hemoglobin following 6 months of continuous subcutaneous insulin infusion in an Indian population with type 2 diabetesJothydev Kesavadev, Shyam Balakrishnan, Shebeer Ahammed, et al.Diabetes Technology & Therapeutics|September 22, 2009
New and improved methods to characterize glycemic variability using continuous glucose monitoringDavid RodbardDiabetes Technology & Therapeutics|September 22, 2009
Accuracy and precision of four value-added blood glucose meters: the Abbott Optium, the DDI Prodigy, the HDI True Track, and the HypoGuard Assure ProCatherine A Sheffield, Michael P Kane, Gary Bakst, et al.Diabetes Technology & Therapeutics|July 8, 2009
Exubera inhaled insulin in patients with type 1 and type 2 diabetes: the first 12 monthsVictoria Alabraba, Adele Farnsworth, Rebecca Leigh, et al.Diabetes Technology & Therapeutics|July 8, 2009
The prescription of insulin pen devices versus syringes for older people with diabetesAmna A Shaghouli, Baiju R ShahDiabetes Technology & Therapeutics|July 8, 2009
Daily glucose profiles in Japanese people with normal glucose tolerance as assessed by continuous glucose monitoringDaisuke Tsujino, Rimei Nishimura, Kentaro Taki, et al.Diabetes Technology & Therapeutics|July 8, 2009
Galvanic skin resistance--a marker for endothelial damage in diabetesJerrold S Petrofsky, Katie McLellanDiabetes Technology & Therapeutics|May 15, 2020
DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin RegimenSylvia Franc, Hélène Hanaire, Pierre-Yves Benhamou, et al.Diabetes Technology & Therapeutics|May 16, 2020
Predicting Factors Associated with Hypoglycemia Reduction with Automated Predictive Insulin Suspension in Patients at High Risk of Severe Hypoglycemia: An Analysis from the SMILE Randomized TrialAklilu Habteab, Javier Castañeda, Harold de Valk, et al.Pageof 282